Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00029146 · ClinicalTrials.gov registry record · Phase 3

Carotid Occlusion Surgery Study

A Phase 3 study, sponsored by University of North Carolina, Chapel Hill.

Terminated
Registry status
Phase 3
Development phase
700
Enrollment target

NCT00029146 is a Phase 3 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 700 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00029146, a Phase 3 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.

TERMINATED
Registry status
Phase 3
Development phase
700 participants
Enrollment target

Study Summary

The purpose of this study is to determine if extracranial-intracranial bypass surgery when added to best medical therapy can reduce the subsequent risk of ipsilateral stroke in high-risk patients with recently symptomatic carotid occlusion and increased cerebral oxygen extraction fraction measured by positron emission tomography (PET).

Interventions

  • PROCEDURE extracranial-intracranial bypass surgery
  • DRUG best medical therapy

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2002-07
Est. Completion 2010-06
Phase Phase 3

What the Registry Record Tells You About NCT00029146

The ClinicalTrials.gov registry entry for NCT00029146 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which extracranial-intracranial bypass surgery is the first listed.

NCT00029146 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00029146 about?

NCT00029146 is a clinical study titled "Carotid Occlusion Surgery Study". The purpose of this study is to determine if extracranial-intracranial bypass surgery when added to best medical therapy can reduce the subsequent risk of ipsilateral stroke in high-risk patients with recently symptomatic carotid occlusion and increased cerebral oxygen extraction fraction measured b...

What is the current status of trial NCT00029146?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 700 participants. The study started on 2002-07. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00029146?

The interventions under investigation include: extracranial-intracranial bypass surgery (PROCEDURE), best medical therapy (DRUG).

Who is sponsoring clinical trial NCT00029146?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.